Alpha 2.0
Login Register
» Authors » Afzalhussein Yusufali

Afzalhussein Yusufali

Explore the profile of Afzalhussein Yusufali including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 58
Citations 5286
Followers 0
Related Specialties
General Medicine
Public Health
Cardiology & Vascular Diseases
Top 10 Co-Authors
Sumathy Rangarajan
Salim Yusuf
Patricio Lopez-Jaramillo
Alvaro Avezum
Annika Rosengren
Jephat Chifamba
Fernando Lanas
Romaina Iqbal
Rafael Diaz
Rajeev Gupta
Published In
Lancet
Diabetes Care
Lancet Diabetes Endocrinol
BMJ Glob Health
Eur Heart J Suppl
Affiliations
Soon will be listed here.
Recent Articles
1.
Assessing the built environment through photographs and its association with obesity in 21 countries: the PURE Study
Corsi D, Marschner S, Lear S, Hystad P, Rosengren A, Ismail R, et al.
Lancet Glob Health . 2024 Sep; 12(11):e1794-e1806. PMID: 39348833
Background: The built environment can influence human health, but the available evidence is modest and almost entirely from urban communities in high-income countries. Here we aimed to analyse built environment...
2.
Use of Cardiovascular Disease Secondary Prevention Medications in Four Middle East Countries in a Community Setting
Yusufali A, Zidan M, Khatib R, Kelishadi R, Alhabib K, Alshamsi M, et al.
Glob Heart . 2024 Sep; 19(1):70. PMID: 39219849
Background: Evidence-based International clinical practice guidelines, universally recommend secondary prevention medications for those with previous cardiovascular disease (CVD). There is limited data on the community use of these medications in...
3.
Activity limitations, use of assistive devices, and mortality and clinical events in 25 high-income, middle-income, and low-income countries: an analysis of the PURE study
Joundi R, Hu B, Rangarajan S, Leong D, Islam S, Smith E, et al.
Lancet . 2024 Jul; 404(10452):554-569. PMID: 39068950
Background: The focus of most epidemiological studies has been mortality or clinical events, with less information on activity limitations related to basic daily functions and their consequences. Standardised data from...
4.
Associations of the glycaemic index and the glycaemic load with risk of type 2 diabetes in 127 594 people from 20 countries (PURE): a prospective cohort study
Miller V, Jenkins D, Dehghan M, Srichaikul K, Rangarajan S, Mente A, et al.
Lancet Diabetes Endocrinol . 2024 Apr; 12(5):330-338. PMID: 38588684
Background: The association between the glycaemic index and the glycaemic load with type 2 diabetes incidence is controversial. We aimed to evaluate this association in an international cohort with diverse...
5.
Tobacco use and risk of acute stroke in 32 countries in the INTERSTROKE study: a case-control study
Wang X, Liu X, ODonnell M, McQueen M, Sniderman A, Pare G, et al.
EClinicalMedicine . 2024 Mar; 70:102515. PMID: 38516107
Background: Smoking is a major risk factor for the global burden of stroke. We have previously reported a global population attributable risk (PAR) of stroke of 12.4% associated with current...
6.
Diet, cardiovascular disease, and mortality in 80 countries
Mente A, Dehghan M, Rangarajan S, ODonnell M, Hu W, Dagenais G, et al.
Eur Heart J . 2023 Jul; 44(28):2560-2579. PMID: 37414411
Aims: To develop a healthy diet score that is associated with health outcomes and is globally applicable using data from the Prospective Urban Rural Epidemiology (PURE) study and replicate it...
7.
Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study
Lopez-Jaramillo P, Gomez-Arbelaez D, Martinez-Bello D, Abat M, Alhabib K, Avezum A, et al.
Lancet Healthy Longev . 2022 Dec; 4(1):e23-e33. PMID: 36521498
Background: The triglyceride glucose (TyG) index is an easily accessible surrogate marker of insulin resistance, an important pathway in the development of type 2 diabetes and cardiovascular diseases. However, the...
8.
Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
Eikelboom J, Jolly S, Belley-Cote E, Whitlock R, Rangarajan S, Xu L, et al.
Lancet Respir Med . 2022 Oct; 10(12):1169-1177. PMID: 36228641
Background: COVID-19 disease is accompanied by a dysregulated immune response and hypercoagulability. The Anti-Coronavirus Therapies (ACT) inpatient trial aimed to evaluate anti-inflammatory therapy with colchicine and antithrombotic therapy with the...
9.
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
Eikelboom J, Jolly S, Belley-Cote E, Whitlock R, Rangarajan S, Xu L, et al.
Lancet Respir Med . 2022 Oct; 10(12):1160-1168. PMID: 36228639
Background: The large number of patients worldwide infected with the SARS-CoV-2 virus has overwhelmed health-care systems globally. The Anti-Coronavirus Therapies (ACT) outpatient trial aimed to evaluate anti-inflammatory therapy with colchicine...
10.
Association of Sitting Time With Mortality and Cardiovascular Events in High-Income, Middle-Income, and Low-Income Countries
Li S, Lear S, Rangarajan S, Hu B, Yin L, Bangdiwala S, et al.
JAMA Cardiol . 2022 Jun; 7(8):796-807. PMID: 35704349
Importance: High amounts of sitting time are associated with increased risks of cardiovascular disease (CVD) and mortality in high-income countries, but it is unknown whether risks also increase in low-...